Alexza Pharmaceuticals Inc. Debt Instrument, Convertible, Beneficial Conversion Feature
Alexza Pharmaceuticals Inc. reported Debt Instrument, Convertible, Beneficial Conversion Feature of $1.03 million for the 12-month period ending 2014-12-31, per its 10-K filed 2016-03-28.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature · last filed 2016-03-28
- Alexza Pharmaceuticals Inc. debt instrument, convertible, beneficial conversion feature for fiscal 2014 was $1.03M, a 66.84% decline from fiscal 2013.
- Alexza Pharmaceuticals Inc. debt instrument, convertible, beneficial conversion feature for fiscal 2013 was $3.11M.
| Period end | Debt Instrument, Convertible, Beneficial Conversion Feature 12 month |
|---|---|
| 2014-12-31 | $1.03M 10-K · filed 2016-03-28 |
| 2013-12-31 | $3.11M 10-K · filed 2016-03-28 |